Researchers sought to assess the safety and efficacy of efgartigimod in patients with AChR-Ab– generalized myasthenia gravis in the ADAPT-SC study population.

Researchers sought to determine the prevalence of amyloidosis in patients undergoing carpal tunnel release.

Researchers sought to compare disease history and clinical exam findings between Black and White patients with CMT type 1A.

Researchers sought to compare all-cause and MG-related inpatient admissions, outpatient specialist visits, and associated costs during the first and second year following a MG diagnosis.

In a phase 3 study, researchers assessed whether myasthenia gravis symptoms worsened during treatment with zilucoplan.

Researchers sought to compare the survival of patients with Duchenne muscular dystrophy treated with eteplirsen vs natural history control individuals.

Researchers sought to assess the effect of fSCIG on patient-reported outcomes, including treatment satisfaction, preference, and convenience, in chronic inflammatory demyelinating polyradiculoneuropathy.

Researchers analyzed neurofilament light chain levels among patients with hATTR amyloidosis who receive treatment with patisiran or vutrisiran.

In a network meta-analysis, researchers compared the effect of new treatments on health-related quality of life outcomes in patients with generalized myasthenia gravis with anti-acetylcholine receptor antibodies.

In a retrospective analysis, researchers characterized the prevalence and outcomes of neuropsychiatric conditions among patients hospitalized with and without neuromuscular diseases.